The human papillomavirus (HPV) vaccine has already saved an estimated 200 lives from cervical cancer in England, with this figure projected to rise significantly as more people receive the jab, new data suggests.
Research spearheaded by Queen Mary University of London and funded by Cancer Research UK indicates the HPV vaccine is proving highly effective in eliminating cervical cancer nationwide.